HIGHLIGHTS
- who: Ayumi Yoshizaki from the , Institute for Translational France Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan have published the article: Involvement of B cells in the development of systemic sclerosis, in the Journal: (JOURNAL)
- what: This trial evaluated %FVC in 48 patients (25 in the rituximab group and 23 in the placebo group) who had SScassociated interstitial lung disease. For SSc-associated interstitial lung disease, the study showed a 7.7% decrease in %FVC in the control group at 7 months, compared with a 0.4% improvement in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.